Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds
search-icon-img
search-icon-img
Advertisement

Despite tension, India-China trade crosses $100 bn

New Delhi, November 8 Despite a military standoff, India-China trade crossed the $100-billion mark in October this year, according to the data released by China’s General Administration of Customs (GAC) on Sunday. Registering an increase of 22.2 per cent as...
  • fb
  • twitter
  • whatsapp
  • whatsapp
Advertisement

New Delhi, November 8

Despite a military standoff, India-China trade crossed the $100-billion mark in October this year, according to the data released by China’s General Administration of Customs (GAC) on Sunday.

Registering an increase of 22.2 per cent as compared with the same period last year, the GAC data showed overall trade volume between India and China was $102.29 billion, with the balance of trade heavily tilted in favour of Beijing.

Advertisement

China’s exports to India stood at $78.33 billion, while India exported goods worth $23.96 billion to China.

The comparison

$78.33 billion imports from China

$23.96 billion exports to China

While the two countries are ranged against each other on security issues, their economies have been showing complementarities as China heads for the number one position in GDP and India for the third slot, with the US in-between.

Advertisement

China will become world’s largest economy by 2030 while India will become third largest economy by 2050. At present, China is the world’s second largest economy and India fifth. India’s exports to China are mainly of iron ore, cotton and commodities while India largely imports mechanical and electrical machinery and medical supplies.

India has been seeking access for its pharmaceutical products and there was some good news last month when China permitted first anti-cancer drug from India. Indian pharma companies have waited for three years for the actual entry. In 2018, the runaway success of the Chinese movie “Dying to Survive”, highlighting the need to import affordable anti-cancer drugs from India, prompted Beijing to announce the entry of 28 Indian drugs, but there was no action till last month. — TNS

Advertisement
Advertisement
Advertisement
Advertisement
tlbr_img1 Home tlbr_img2 Opinion tlbr_img3 Classifieds tlbr_img4 Videos tlbr_img5 E-Paper